# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k182719   
B. Purpose for Submission: New Device   
C. Measurand: Amphetamine, Methamphetamine, Barbiturates, Benzodiazepines, Cocaine, EDDP (2- ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine), Opiates, Cannabinoids, Tricyclic Antidepressants   
D. Type of Test: Qualitative, lateral flow immunofluorence   
E. Applicant: Quidel Cardiovascular Inc.   
F. Proprietary and Established Names: Quidel Triage® TOX Drug Screen, 94600 Quidel Triage® MeterPro

G. Regulatory Information:

<table><tr><td colspan="1" rowspan="1">Product Code</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">Regulatory Section</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">DKZ</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3100,Amphetamine test system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">LAF</td><td colspan="1" rowspan="1">Class Ⅱ</td><td colspan="1" rowspan="1">21 CFR 862.3610,Methamphetamine test system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">DIS</td><td colspan="1" rowspan="1">Class ⅡI</td><td colspan="1" rowspan="1">21 CFR 862.3150, Barbituratetest system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">JXM</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3170,Benzodiazepine test system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">JXO</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3250, Cocaine andcocaine metabolite test system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">DJR</td><td colspan="1" rowspan="1">Class Ⅱ</td><td colspan="1" rowspan="1">21 CFR 862.3620, Methadonetest system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">DJG</td><td colspan="1" rowspan="1">Class Ⅱ</td><td colspan="1" rowspan="1">21 CFR 862.3650, Opiate testsystem</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">LDJ</td><td colspan="1" rowspan="1">Class Ⅱ</td><td colspan="1" rowspan="1">21 CFR 862.3870, Cannabinoidtest system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">LFG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3910, Tricyclicantidepressant drugs test system</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">KHO</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.2560, Fluorometerfor clinical use</td><td colspan="1" rowspan="1">Chemistry(75)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See Indication(s) for use below.

2. Indication(s) for use:

The Quidel Triage® TOX Drug Screen, 94600 is a fluorescence immunoassay to be used with the Quidel Triage® MeterPro for the qualitative determination of the presence of drugs and/or metabolites in human urine of up to 9 drug assays at or above the threshold concentrations. The threshold concentrations are provided below:

<table><tr><td colspan="1" rowspan="1">Abbreviation</td><td colspan="1" rowspan="1">Analyte</td><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Cutoff</td></tr><tr><td colspan="1" rowspan="1">AMP</td><td colspan="1" rowspan="1">Amphetamines</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">500 ng/mL</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">Methamphetamines</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">500 ng/mL</td></tr><tr><td colspan="1" rowspan="1">BAR</td><td colspan="1" rowspan="1">Barbiturates</td><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">200 ng/mL</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">Benzodiazepines</td><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">200) ng/mL</td></tr><tr><td colspan="1" rowspan="1">COC</td><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">150 ng/mL</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">Methadone Metabolite</td><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">100 ng/mL</td></tr><tr><td colspan="1" rowspan="1">OPI</td><td colspan="1" rowspan="1">Opiates</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">Cannabinoids</td><td colspan="1" rowspan="1">11-nor-9-carboxy-Δ9-THC</td><td colspan="1" rowspan="1">50 ng/mL</td></tr><tr><td colspan="1" rowspan="1">TCA</td><td colspan="1" rowspan="1">TricyclicAntidepressants</td><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">1000 ng/mL</td></tr></table>

This test provides only a preliminary test result. Clinical consideration and professional judgment must be applied to any drug test result, particularly in evaluating a preliminary positive result. A more specific alternate chemical method must be used to obtain a confirmed analytical result. Gas Chromatography / Mass Spectroscopy (GC/MS), Liquid Chromatography / Mass Spectroscopy / Mass Spectroscopy (LC-MS/MS) and High Performance Liquid Chromatography (HPLC) are common confirmatory methods.

The Quidel Triage® MeterPro is a portable fluorescence instrument used to measure the results of tests manufactured by Quidel Cardiovascular Inc. The Quidel Triage® MeterPro can be used in a laboratory or in a point-of-care setting.

3. Special conditions for use statement(s): For prescription use only.

4. Special instrument requirements: Quidel Triage® MeterPro

# I. Device Description:

The Quidel Triage® TOX Drug Screen, 94600 is a single use test device, and is used in conjunction with the Quidel Triage® MeterPro. The device is a competitive-based lateral flow fluorescence immunoassay and contains murine monoclonal antibody conjugates (depending on the test analyte) and drug conjugates labeled with a fluorescent dye or immobilized on the solid phase and stabilizers.

The Quidel Triage® TOX Drug Screen, 94600 is inserted into and read by the Quidel Triage® MeterPro. Threshold concentrations are factory calibrated and are used to determine a negative result or a presumptive positive result for the presence of the major urinary metabolites of the following substances in human urine: amphetamine (AMP), methamphetamine (mAMP), barbiturates (BAR), benzodiazepines (BZO), cocaine (COC), methadone metabolite, (2- ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine), (EDDP), opiates (OPI), cannabinoid (THC), and tricyclic antidepressants (TCA).

The Quidel Triage TOX Drug Screen, 94600 Test is provided as a kit that contains 25 test devices, 25 transfer pipettes, one reagent CODE CHIP Module and 2 printer paper rolls. The test device is individually wrapped for one time use only.

Quidel Triage® MeterPro, and Quidel Triage TOX Drug Screen, 94600 Control 1 and 2 are needed but not provided with the kit.

The Quidel Triage® MeterPro is a portable fluorescence instrument. It uses a laser diode as the excitation light source and a silicon photodiode as the light detector for the reaction. Light from the laser hits a test device that has been inserted in the meter. This causes the fluorescent dye in the test device to give off energy, and this fluorescence is captured by the light detector. The amount of fluorescence produced directly correlates with analyte concentrations in an analyte-specific manner. Results are displayed on a liquid crystal display or hard copies can be printed via the internal printer.

# J. Substantial Equivalence Information:

1. Predicate device name(s):

GenPrime Drugs of Abuse (DOA) Reader System   
Immunalysis Barbiturates Urine Enzyme Immunoassay   
DRI Benzodiazepine Assay   
Immunalysis EDDP Specific Urine Enzyme Immunoassay   
Biosite Incorporated Triage TOX Drug Screen   
Biosite Incorporated Triage Meter

2. Predicate 510(k) number(s):

k130082, GenPrime Drugs of Abuse (DOA) Reader System   
k161714, Immunalysis Barbiturates Urine Enzyme Immunoassay   
k173963, DRI Benzodiazepine Assay   
k151395, Immunalysis EDDP Specific Urine Enzyme Immunoassay   
k043242, Biosite Incorporated Triage® TOX Drug Screen   
k973547, Biosite Incorporated Triage® Meter

3. Comparison with predicate:

Quidel Triage® TOX Drug Screen, 94600:

Assays: Amphetamines (AMP), Methamphetamines (mAMP), Cocaine (COC), Opiates (OPI), and Cannabinoids (THC)

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Quidel TriageTOX DrugScreen, 94600(Proposed Device)</td><td colspan="1" rowspan="1">GenPrime Drugs of Abuse(DOA) Reader System(K130082)(Predicate Device)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For the qualitativedetermination of drugs ofabuse in human urine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Intended Population</td><td colspan="1" rowspan="1">Prescription use</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay Type</td><td colspan="1" rowspan="1">Competitive assay whereconcentration of drug isinversely related to thesignal detected by theinstrument.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">System Procedure</td><td colspan="1" rowspan="1">Sample is added to a singleuse test device which isthen read by theinstrument. The instrumentis designed to read multipleassays at the same time.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Single-use Test Device</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Analyte Cutoffs (ng/mL)</td><td colspan="1" rowspan="1">AMP = 500mAMP = 500COC = 150OPI = 300THC = 50</td><td colspan="1" rowspan="1">AMP = 500 (OS Cup; SKCup)MET = 500 (OS Cup; SKCup)COC = 150 (OS Cup)MOP = 300 (SK Cup)THC = 50 (OS Cup; SKCup)</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage®TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>GenPrime Drugs of Abuse(DOA) Reader System(K130082)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Test Device Reader</td><td rowspan=1 colspan=1>Quidel Triage®MeterPro</td><td rowspan=1 colspan=1>GenPrime DOA Reader</td></tr><tr><td rowspan=1 colspan=1>Analyte Cutoffs (ng/mL)</td><td rowspan=1 colspan=1>BAR = 200BZO = 200EDDP = 100TCA = 1000MTD, OXY, PCP are notpanel assays and have noassociated analyte cutoffs.</td><td rowspan=1 colspan=1>BAR = 300 (OS Cup)MTD = 300 (SK Cup)MOP = 2000 (SK Cup)PCP = 25 (SK Cup)BZO, EDDP, and TCA arenot panel assays and haveno associated cutoff.</td></tr><tr><td rowspan=1 colspan=1>Test Device Format</td><td rowspan=1 colspan=1>Cassette</td><td rowspan=1 colspan=1>Cup</td></tr></table>

Assay: Barbiturates (BAR)   

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage® TOX DrugScreen,94600(Proposed Device)</td><td rowspan=1 colspan=1>ImmunalysisBarbituratesUrine EnzymeImmunoassay(K161714)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For the qualitativedetermination of drugs ofabuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-8°</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measured Analyte</td><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyte Cutoff(ng/mL)</td><td rowspan=1 colspan=1>BAR = 200</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage®TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>ImmunalysisBarbituratesUrine EnzymeImmunoassay (K161714)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Antibody Type</td><td rowspan=1 colspan=1>Mouse monoclonalantibodies</td><td rowspan=1 colspan=1>Recombinant andmonoclonal antibodies</td></tr></table>

Assay: Benzodiazepines (BZO)   

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td colspan="1" rowspan="1">DRI Benzodiazepine Assay(K173963)(Predicate Device)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For the qualitativedetermination of drugs ofabuse in human urine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Storage</td><td colspan="1" rowspan="1">2-8°</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Analyte Cutoff(ng/mL)</td><td colspan="1" rowspan="1">BZO = 200</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td colspan="1" rowspan="1">DRI Benzodiazepine Assay(K173963)(Predicate Device)</td></tr><tr><td colspan="1" rowspan="1">Antibody Type</td><td colspan="1" rowspan="1">Mouse monoclonalantibodies</td><td colspan="1" rowspan="1">Polyclonal sheep antibody</td></tr></table>

Assay: 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)   

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>Immunalysis EDDPSpecific Urine EnzymeImmunoassay(K151395)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For the qualitativedetermination of drugs ofabuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-8°C</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Assay calibrated</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measured Analyte</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyte Cutoff(ng/mL)</td><td rowspan=1 colspan=1>EDDP = 100</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>Immunalysis EDDPSpecific Urine EnzymeImmunoassay(K151395)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Antibody Type</td><td rowspan=1 colspan=1>Mouse monoclonalantibodies</td><td rowspan=1 colspan=1>Recombinant fab antibodies</td></tr></table>

Assay: Tricyclic Antidepressants (TCA)   

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>Triage®TOX Drug Screen(K043242)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For the qualitativedetermination of drugs ofabuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Assay Type</td><td rowspan=1 colspan=1>Competitive assay, whereconcentration of drug isinversely related to thesignal detected by theinstrument.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-8°</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Detection method</td><td rowspan=1 colspan=1>Measures fluorescence ofdiscreet measurement zonesfor each assay.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Assay calibrated</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measured Analyte</td><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyte Cutoff(ng/mL)</td><td rowspan=1 colspan=1>TCA = 1000</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Quidel Triage® TOX DrugScreen, 94600(Proposed Device)</td><td rowspan=1 colspan=1>Triage®TOX Drug Screen(K043242)(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Amphetamines,Methamphetamines,Barbiturates,Benzodiazepines, Cocaine,Methadone Metabolite,Opiates, Cannabinoids(THC), and TricyclicAntidepressants</td><td rowspan=1 colspan=1>Acetaminophen,Amphetamines,Methamphetamines,Barbiturates,Benzodiazepines, Cocaine,Opiates, Phencyclidine,THC, and TricyclicAntidepressants</td></tr></table>

Quidel Triage MeterPro:   

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Quidel Triage® MeterPro(Proposed Device)</td><td colspan="1" rowspan="1">Triage Meter(K973547)(Predicate Device)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Fluorometer for themeasurement offluorescence in variousassay systems.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Device Class</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Power supply</td><td colspan="1" rowspan="1">100-240 VAC, self-switching, or with 4 AAbatteries</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Max. Voltage of ext.power supply</td><td colspan="1" rowspan="1">20 V</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Electrostaticprotection to serialport</td><td colspan="1" rowspan="1">8 /15 kV</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Number of serialports</td><td colspan="1" rowspan="1">2 (by use of adapter)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Printer</td><td colspan="1" rowspan="1">Integrated</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample ID</td><td colspan="1" rowspan="1">Manual input or externalhand-held barcode scanner</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Barcode</td><td colspan="1" rowspan="1">Integrated barcode on eachtest device with lot specificinformation</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Time to result</td><td colspan="1" rowspan="1">Approximately 15  20minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Output</td><td colspan="1" rowspan="1">Outputs are "POS" if theresult is at or above thethreshold concentration or"NEG" if the result isbelow the thresholdconcentration. Theoperator has the option toprint the results.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Quidel Triage®MeterPro(Proposed Device)</td><td colspan="1" rowspan="1">Triage Meter(K973547)(Predicate Device)</td></tr><tr><td colspan="1" rowspan="1">Top meter housing</td><td colspan="1" rowspan="1">New top meter housingmold to provide a largerliquid crystal display (LCD)and two elastomer keypads</td><td colspan="1" rowspan="1">Small LCD with one singlemembrane keyboard</td></tr><tr><td colspan="1" rowspan="1">Output</td><td colspan="1" rowspan="1">If connected, the MeterProcan transmit results to thelaboratory or hospitalinformation system.</td><td colspan="1" rowspan="1">The Triage Meter does nothave capability to transmitresults to the laboratory orhospital information system.</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced.

# L. Test Principle:

The Quidel Triage TOX Drug Screen, 94600 is a competitive fluorescence immunoassay which contains all the reagents necessary for the qualitative detection, relative to an assigned threshold value, of the major urinary metabolites of the following substances in human urine: amphetamine (AMP), methamphetamine (mAMP), barbiturates (BAR), benzodiazepines (BZO), cocaine (COC), methadone/methadone metabolite (EDDP), opiates (OPI), tetrahydrocannabinol (THC), and tricyclic antidepressants (TCA).

The tests use monoclonal antibodies against 9 targeted drugs or metabolites in the patient urine sample. The tests utilize a competitive immunoassay format in which the fluorescence results are inversely proportional to the analyte concentration. If the assay spot concentration is less than the assay-specific threshold then the result will be reported as positive. If the assay spot concentration is equal to or greater than the test-specific threshold then the result will be reported as negative.

The tests contain positive on-board test device controls. Before calculating whether the test is positive or negative for each assay spot, the algorithm checks to ensure that the acceptance criteria for the on-board test device controls have been met. If any have not been met, the assay result is reported as invalid.

The test procedure involves the addition of a urine specimen to the sample port on the Test Device. After addition of the specimen, the urine passes through a filter. The specimen reacts with fluorescent antibody conjugates or with fluorescent drug conjugates and flows through the Test Device by capillary action. The presence of drug or drug metabolite in the urine specimen prevents binding of the fluorescent conjugates to the solid phase on the detection zone. Excess urine washes the unbound fluorescent conjugates from the detection

lane into a waste reservoir.

The Test Device is inserted into the Quidel Triage® MeterPro. The Quidel Triage® MeterPro is programmed to perform the analysis after the specimen has reacted with the reagents in the Test Device. The analysis is based on the amount of fluorescence the Quidel Triage® MeterPro detects within a measurement zone on the Test Device. The positive or negative results are displayed on the Quidel Triage® MeterPro screen at a specified time after the addition of specimen. All results are stored in the Quidel Triage MeterPro memory to display or print when needed. If connected, the Quidel Triage® MeterPro can transmit results to the laboratory or hospital information system.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

Each analyte for the precision study was tested at the following concentrations, as percentages of the cutoffs: A negative control, drug free, $2 5 \%$ , $50 \%$ , $7 5 \%$ , cutoff, $12 5 \%$ , $1 5 0 \%$ , $1 7 5 \%$ , and $20 \%$ . The panels were blinded and randomized prior to testing. Testing was performed at three representative point of care (POC) sites using three device lots and 45 meters. Three operators conducted the testing at each POC site. Each operator was assigned one test device lot and five Triage MeterPro instruments to conduct the testing. Each operator tested ten samples each day of testing. The ten samples were run in duplicate two times per day for twenty days at each clinical site. Each device was read on one Triage MeterPro. There were approximately 720 results $( \mathrm { N } { = } 4 \mathrm { x } 2 0 \mathrm { x } 9 )$ ) per sample. The test results were interpreted as positive (POS) or negative (NEG) for each individual assay based on the assay specific cut-off concentration values. The results of the testing are summarized as follow for the test device.

<table><tr><td colspan="1" rowspan="1">Actual DrugConcentration(ng/mL)</td><td colspan="1" rowspan="1">Target DrugLevels (% ofCutoff)</td><td colspan="1" rowspan="1">Number ofReplicates(N)</td><td colspan="1" rowspan="1">Number ofNegativeResults</td><td colspan="1" rowspan="1">Number ofPositiveResults</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="5" rowspan="1">AMP (500 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">126</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">281</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">712</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">395</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">694</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">522</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">669</td></tr><tr><td colspan="1" rowspan="1">650</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">760</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">884</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">704</td></tr><tr><td colspan="1" rowspan="1">991</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">736</td></tr><tr><td colspan="5" rowspan="1">mAMP (500 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeCControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">130</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">366</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">697</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">529</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">281</td><td colspan="1" rowspan="1">431</td></tr><tr><td colspan="1" rowspan="1">652</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">707</td></tr><tr><td colspan="1" rowspan="1">742</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">872</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">961</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">704</td></tr><tr><td colspan="5" rowspan="1">BAR (200 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeL Control</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">53</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">108</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">156</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">689</td><td colspan="1" rowspan="1">31</td></tr><tr><td colspan="1" rowspan="1">192</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">605</td></tr><tr><td colspan="1" rowspan="1">233</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">717</td></tr><tr><td colspan="1" rowspan="1">306</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">719</td></tr><tr><td colspan="1" rowspan="1">355</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">722</td></tr><tr><td colspan="1" rowspan="1">406</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="5" rowspan="1">BZO (200 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">58</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">107</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">735</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">166</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">626</td><td colspan="1" rowspan="1">94</td></tr><tr><td colspan="1" rowspan="1">219</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">318</td><td colspan="1" rowspan="1">402</td></tr><tr><td colspan="1" rowspan="1">259</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">707</td></tr><tr><td colspan="1" rowspan="1">306</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">378</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">719</td></tr><tr><td colspan="1" rowspan="1">399</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">722</td></tr><tr><td colspan="5" rowspan="1">COC (150 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">76</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">119</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">519</td><td colspan="1" rowspan="1">203</td></tr><tr><td colspan="1" rowspan="1">157</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">694</td></tr><tr><td colspan="1" rowspan="1">185</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">704</td></tr><tr><td colspan="1" rowspan="1">218</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">736</td></tr><tr><td colspan="1" rowspan="1">267</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="5" rowspan="1">EDDP (100 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">52</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">702</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">85</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">645</td><td colspan="1" rowspan="1">91</td></tr><tr><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">126</td><td colspan="1" rowspan="1">594</td></tr><tr><td colspan="1" rowspan="1">136</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">715</td></tr><tr><td colspan="1" rowspan="1">143</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">716</td></tr><tr><td colspan="1" rowspan="1">174</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">204</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">719</td></tr><tr><td colspan="5" rowspan="1">OPI (300 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">165</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">231</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">715</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">344</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">197</td><td colspan="1" rowspan="1">507</td></tr><tr><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">731</td></tr><tr><td colspan="1" rowspan="1">480</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">548</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="1" rowspan="1">589</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">716</td></tr><tr><td colspan="5" rowspan="1">THC (50 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">717</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">676</td><td colspan="1" rowspan="1">43</td></tr><tr><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">163</td><td colspan="1" rowspan="1">559</td></tr><tr><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">719</td></tr><tr><td colspan="1" rowspan="1">78</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">700</td></tr><tr><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">735</td></tr><tr><td colspan="1" rowspan="1">103</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr><tr><td colspan="5" rowspan="1">TCA (1,000 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">236</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">722</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">498</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">719</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">741</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">704</td><td colspan="1" rowspan="1">618</td><td colspan="1" rowspan="1">86</td></tr><tr><td colspan="1" rowspan="1">996</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">736</td><td colspan="1" rowspan="1">218</td><td colspan="1" rowspan="1">518</td></tr><tr><td colspan="1" rowspan="1">1,395</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">715</td></tr><tr><td colspan="1" rowspan="1">1,577</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">719</td></tr><tr><td colspan="1" rowspan="1">1,716</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">716</td></tr><tr><td colspan="1" rowspan="1">2,195</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">720</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">720</td></tr></table>

b. Linearity/assay reportable range:

Not applicable. These devices are intended for qualitative use only.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Quidel Triage TOX Drug Screen, 94600 Cold Storage Stability

A shelf-life stability study of the test was performed and the results showed that devices are stable for 3 months when stored in cold storage ( $2 ^ { \circ } \mathrm { C }$ to $8 ^ { \circ } \mathrm { C }$ ). Real time stability studies are ongoing and shelf life will be extended based upon data meeting the acceptance criteria.

# Room Temperature Stability

A shelf-life stability study of the test was performed and the results showed that devices are stable for 14 days when stored at room temperature $2 0 ^ { \circ } \mathrm { C }$ to $2 4 ^ { \circ } \mathrm { C }$ ). Room temperature stability studies are ongoing and shelf life will be extended based upon data meeting the acceptance criteria.

# Patient Sample Handling Stability

A patient sample handling stability study of the test was performed and patient sample results were found to be stable when used within 36 hours of sample collection at room temperature ( $2 0 ^ { \circ } \mathrm { C }$ to $2 4 ^ { \circ } \mathrm { C }$ ) and within four days when stored refrigerated ( $2 ^ { \circ } \mathrm { C }$ to $8 ^ { \circ } \mathrm { C }$ ). No more than a single freeze/thaw cycle is recommended.

d. Detection limit:

See assay cutoff characterization data in Section M.1.a, above, and M.1.f., below, for device performance around the claimed cutoff concentrations.

e. Analytical specificity:

# Analytical Specificity

To test cross-reactivity, drug metabolites and other compounds that may be present in human urine samples were tested using nine lots of Quidel Triage TOX Drug Screen, 94600 Test Devices. The following is a summary of the cross-reactivity study. The individual assays are calibrated against the compounds marked with an asterisk $( ^ { * } )$ .

<table><tr><td colspan="1" rowspan="1">AMP(Cutoff= 500 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">1,850</td><td colspan="1" rowspan="1">27.0</td></tr><tr><td colspan="1" rowspan="1">AMP(Cutoff = 500 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">d,1-1-(3,4-Methylenedioxyphenyl)-2-Butanamine (BDB)</td><td colspan="1" rowspan="1">1,500</td><td colspan="1" rowspan="1">33.3</td></tr><tr><td colspan="1" rowspan="1">d,1-Amphetamine</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">d,1-Phenylpropanolamine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">d-Ephedrine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine*</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">d-Pseudoephedrine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">16.7</td></tr><tr><td colspan="1" rowspan="1">1-Ephedrine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">p-Methoxyamphetamine (PMA)</td><td colspan="1" rowspan="1">1,750</td><td colspan="1" rowspan="1">28.6</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">95,000</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">30,000</td><td colspan="1" rowspan="1">1.7</td></tr><tr><td colspan="1" rowspan="1">p-Chloroamphetamine (PCA)</td><td colspan="1" rowspan="1">2,000</td><td colspan="1" rowspan="1">25.0</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxyamphetamine</td><td colspan="1" rowspan="1">3,500</td><td colspan="1" rowspan="1">14.3</td></tr></table>

<table><tr><td colspan="1" rowspan="1">mAMP(Cutoff= 500ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">2,300</td><td colspan="1" rowspan="1">21.7</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Benzodioxazolybutanamine(BDB)</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">mAMP(Cutoff = 500 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">d,1-Methyl-1(3,4-Methylenedioxyphenyl)2-Butanamine (MBDB)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine*</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">d-Ephedrine</td><td colspan="1" rowspan="1">&gt;150,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Ethylamphetamine</td><td colspan="1" rowspan="1">7,000</td><td colspan="1" rowspan="1">7.1</td></tr><tr><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">10.0</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">1-Ephedrine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Isometheptine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">1.0</td></tr><tr><td colspan="1" rowspan="1">Mephentermine</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">p-Methoxyamphetamine (PMA)</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">p-Methoxymethamphetamine(PMMA)</td><td colspan="1" rowspan="1">2,200</td><td colspan="1" rowspan="1">22.7</td></tr><tr><td colspan="1" rowspan="1">Propylamphetamine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">50.0</td></tr></table>

<table><tr><td colspan="1" rowspan="1">BAR(Cutoff = 200 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Allobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Alphenal</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">80.0</td></tr><tr><td colspan="1" rowspan="1">Aprobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Barbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Butalbital*</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Butethal</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">200.0</td></tr><tr><td colspan="1" rowspan="1">Cyclopentobarbital</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Hexobarbital</td><td colspan="1" rowspan="1">90,000</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1">Mephobarbital</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">6.7</td></tr><tr><td colspan="1" rowspan="1">Phenallymal</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">40.0</td></tr><tr><td colspan="1" rowspan="1">BAR(Cutoff=200ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">230</td><td colspan="1" rowspan="1">87.0</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">700</td><td colspan="1" rowspan="1">28.6</td></tr><tr><td colspan="1" rowspan="1">Thiopental</td><td colspan="1" rowspan="1">80,000</td><td colspan="1" rowspan="1">0.3</td></tr></table>

<table><tr><td colspan="1" rowspan="1">BZO(Cutoff = 200 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">200.0</td></tr><tr><td colspan="1" rowspan="1">Alprazolam, -OH</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">133.3</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">26.7</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">8,000</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">26.7</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">650</td><td colspan="1" rowspan="1">30.8</td></tr><tr><td colspan="1" rowspan="1">Clonazepam, 7-amino</td><td colspan="1" rowspan="1">26,000</td><td colspan="1" rowspan="1">0.8</td></tr><tr><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">1,200</td><td colspan="1" rowspan="1">16.7</td></tr><tr><td colspan="1" rowspan="1">Delorazepam</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">57.1</td></tr><tr><td colspan="1" rowspan="1">Demoxepam</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">Desalkylflurazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">125</td><td colspan="1" rowspan="1">160.0</td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam, 7-amino</td><td colspan="1" rowspan="1">6,000</td><td colspan="1" rowspan="1">3.3</td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">250.0</td></tr><tr><td colspan="1" rowspan="1">Halazepam</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">80</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Lorazepam glucuronide</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">200.0</td></tr><tr><td colspan="1" rowspan="1">Medazepam</td><td colspan="1" rowspan="1">9,000</td><td colspan="1" rowspan="1">2.2</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">2,600</td><td colspan="1" rowspan="1">7.7</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam, 7-amino</td><td colspan="1" rowspan="1">&gt;150,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Norchlordiazepoxide</td><td colspan="1" rowspan="1">7,000</td><td colspan="1" rowspan="1">2.9</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">1,100</td><td colspan="1" rowspan="1">18.2</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">2,500</td><td colspan="1" rowspan="1">8.0</td></tr><tr><td colspan="1" rowspan="1">Oxazepam glucuronide</td><td colspan="1" rowspan="1">1,250</td><td colspan="1" rowspan="1">16.0</td></tr><tr><td colspan="1" rowspan="1">Prazepam</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">57.1</td></tr><tr><td colspan="1" rowspan="1">Temazepam*</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Temazepamglucuronide</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">200.0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>COC(Cutoff = 150 ng/mL)</td><td rowspan=1 colspan=1>ResultsPositive at(ng/mL)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine*</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>50,000</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Ecgonine</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Ecgonine methyl ester</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Hydroxybenzoylecgonine, m-</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>37.5</td></tr><tr><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>EDDP(Cutoff = 100 ng/mL)</td><td rowspan=1 colspan=1>ResultsPositive at(ng/mL)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>EDDP*</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>EMDP</td><td rowspan=1 colspan=1>40,000</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>1-methadone</td><td rowspan=1 colspan=1>160,000</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td rowspan=1 colspan=1>d-methadone</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>d/l-methadone</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>1-β-Acetylmethadol (LAAM)</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>1-iso-methadone</td><td rowspan=1 colspan=1>&gt;100,000</td><td rowspan=1 colspan=1>0.0</td></tr></table>

<table><tr><td colspan="1" rowspan="1">OPI(Cutoff = 300 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">6-Acetylcodeine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150.0</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150.0</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">&gt;40,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150.0</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">120</td><td colspan="1" rowspan="1">250.0</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">700</td><td colspan="1" rowspan="1">42.9</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">1,100</td><td colspan="1" rowspan="1">27.3</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">1.2</td></tr><tr><td colspan="1" rowspan="1">Morphine*</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Morphine 3- glucuronide</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">10.0</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">&gt;230,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Nor-Buprenorphine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">&gt;300,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">0.6</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">35,000</td><td colspan="1" rowspan="1">0.9</td></tr></table>

<table><tr><td rowspan=1 colspan=1>THC(Cutoff = 50 ng/mL)</td><td rowspan=1 colspan=1>ResultsPositive at(ng/mL)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>11-nor-9 carboxy-Δ9-THC*</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ8-THC-COOH</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>11-nor-9 carboxy-∆9-THC-glucuronide</td><td rowspan=1 colspan=1>17,000</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>&gt;200,000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Cannabinol, Δ8-</td><td rowspan=1 colspan=1>3,000</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>Cannabinol, ∆9-</td><td rowspan=1 colspan=1>3,000</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>Tetrahydocannabinol</td><td rowspan=1 colspan=1>3,000</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>(+/-) 11-hydroxy- ∆9-THC</td><td rowspan=1 colspan=1>1,500</td><td rowspan=1 colspan=1>3.3</td></tr></table>

<table><tr><td colspan="1" rowspan="1">TCA(Cutoff = 1,000 ng/mL)</td><td colspan="1" rowspan="1">ResultsPositive at(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">166.7</td></tr><tr><td colspan="1" rowspan="1">Amitryptyline metabolite</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">333.3</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">&gt;400,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Chlorprothixene</td><td colspan="1" rowspan="1">40,000</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">10.0</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">1,400</td><td colspan="1" rowspan="1">71.4</td></tr><tr><td colspan="1" rowspan="1">Desipramine*</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">1,300</td><td colspan="1" rowspan="1">76.9</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">166.7</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">240,000</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1">1,500</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">111.1</td></tr><tr><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">175,000</td><td colspan="1" rowspan="1">0.6</td></tr><tr><td colspan="1" rowspan="1">Phenothiazine</td><td colspan="1" rowspan="1">280,000</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">35,000</td><td colspan="1" rowspan="1">2.9</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">&gt;200,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">2,500</td><td colspan="1" rowspan="1">40.0</td></tr><tr><td colspan="1" rowspan="1">Thiothixene</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">0.0</td></tr><tr><td colspan="1" rowspan="1">Trimeprazine</td><td colspan="1" rowspan="1">83,500</td><td colspan="1" rowspan="1">1.2</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">3,800</td><td colspan="1" rowspan="1">26.3</td></tr></table>

Cross Reactivity and Interference Testing of Non-Structurally Related Pharmaceutical Compounds

Potential interference from pharmaceutical compounds were tested by spiking the potentially interfering pharmaceutical compound at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ into drug-free urine containing the target drug concentrations at $50 \%$ below and $50 \%$ above the threshold cutoff level. The following compounds, arranged in alphabetical order, were found not to cross react when tested at concentration up to at least 100 $\mu \mathrm { g / m L }$ . For the pharmaceutical compounds where interference was observed, the highest concentration that did not cause interference is indicated in the table below, along with the assay in which it interfered.

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Dronabinol (1 μg/mL;THC)</td><td colspan="1" rowspan="1">Olanzapine</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Droperidol</td><td colspan="1" rowspan="1">Oxalic Acid</td></tr><tr><td colspan="1" rowspan="1">Acetopromazine(maleate salt)</td><td colspan="1" rowspan="1">Duloxetine</td><td colspan="1" rowspan="1">Oxaprozin</td></tr><tr><td colspan="1" rowspan="1">Amantadine</td><td colspan="1" rowspan="1">Efavirenz</td><td colspan="1" rowspan="1">Pantoprazole</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">L-Epinephrine</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Fenfluramine (2μg/mL; AMP andmAMP)</td><td colspan="1" rowspan="1">Pentazocine</td></tr><tr><td colspan="1" rowspan="1">Aspirin (salicyluric</td><td colspan="1" rowspan="1">Flunitrazepam (0.2</td><td colspan="1" rowspan="1">Pericyazine</td></tr><tr><td colspan="1" rowspan="1">acid)</td><td colspan="1" rowspan="1">μg/mL; BZO)</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Atenolol</td><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Atorvastatin</td><td colspan="1" rowspan="1">Gamma-Hydroxybutyrate</td><td colspan="1" rowspan="1">Phenethylamine (2-Phenylethyamine) (6μg/mL; AMP)</td></tr><tr><td colspan="1" rowspan="1">Benzocaine</td><td colspan="1" rowspan="1">Glutethimide (10μg/mL; BAR)</td><td colspan="1" rowspan="1">Phenmetrazine (37.5μg/mL; TCA)</td></tr><tr><td colspan="1" rowspan="1">Benzydamine</td><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Phenylephrine</td></tr><tr><td colspan="1" rowspan="1">Benztropine Methane</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Phenylhydantoin,d/1-5(p-hydroxyphenyl)-5-</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">KetorolacTromethamine</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Butyrophenone</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">Levofloxacin</td><td colspan="1" rowspan="1">Propranolol, d/1</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">Levorphanol (18.75μg/mL; OPI)</td><td colspan="1" rowspan="1">d-Pseudoephedrine(50 μg/mL; THC)</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Quetiapine</td></tr><tr><td colspan="1" rowspan="1">Cimetidine</td><td colspan="1" rowspan="1">Mesoridazine Besylate</td><td colspan="1" rowspan="1">Quinacrine (50μg/mL; THC)</td></tr><tr><td colspan="1" rowspan="1">Citalopram</td><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Clomipramine (5μg/mL; TCA)</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Rifampin</td></tr><tr><td colspan="1" rowspan="1">Cotinine [1-Cotinine]</td><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">Ritodrine</td></tr><tr><td colspan="1" rowspan="1">Cyproheptadine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Selegiline</td></tr><tr><td colspan="1" rowspan="1">Dexamphetamine (0.4μg/mL; AMP)</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Sertraline</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Naproxen [(S)-6-Methoxy-α-methyl-2Naphthaleneacetic acid]</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Dextrorphan Tartrate</td><td colspan="1" rowspan="1">N-desmethylvenlafaxine</td><td colspan="1" rowspan="1">Tramadol</td></tr><tr><td colspan="1" rowspan="1">Dimethylamine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Tranylcypromine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Nicotine</td><td colspan="1" rowspan="1">Trimethobenzamide</td></tr><tr><td colspan="1" rowspan="1">Dopamine</td><td colspan="1" rowspan="1">Norpseudoephedrine(25 μg/mL; AMP)</td><td colspan="1" rowspan="1">Tyramine (25μg/mL; AMP)</td></tr><tr><td colspan="1" rowspan="1">Dothiepin (0.7 μg/mL;TCA)</td><td colspan="1" rowspan="1">O-desmethylvenlafaxine</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Doxylamine Succinate</td><td colspan="1" rowspan="1">d,1-Octopamine</td><td colspan="1" rowspan="1">Zolpidem</td></tr><tr><td colspan="1" rowspan="1">Doxepin (0.65 μg/mL;TCA)</td><td colspan="1" rowspan="1">Ofloxacin</td><td colspan="1" rowspan="1">Benzphetamine</td></tr><tr><td colspan="1" rowspan="1">Clobenzorex</td><td colspan="1" rowspan="1">Fenproporex</td><td colspan="1" rowspan="1">Meprobamate</td></tr><tr><td colspan="1" rowspan="1">Nalmefene</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr></table>

# Interference from Exogenous Compounds

Potential interference from exogenous compounds were tested by spiking the potentially interfering compound into treated drug-free urine containing the target drug concentrations at $50 \%$ below and $50 \%$ above the threshold cutoff level. The following exogenous compounds were found not to interfere with test results when tested up to the concentrations identified in the table below.

<table><tr><td rowspan=1 colspan=1>Interfering Substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>1 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>1 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>15 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>0.125 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Fluoxetine</td><td rowspan=1 colspan=1>0.5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Hippuric Acid</td><td rowspan=1 colspan=1>10 μg/mL</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>0.75 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Ketamine</td><td rowspan=1 colspan=1>25 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>7 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>75 μg/mL</td></tr><tr><td rowspan=1 colspan=1>Scopalamine</td><td rowspan=1 colspan=1>62.5 μg/mL</td></tr></table>

# Interference from Endogenous Compounds

Potential interference from endogenous compounds were tested by spiking the potentially interfering compound into drug-free urine containing the target drug concentrations at $50 \%$ below and $50 \%$ above the threshold cutoff level. The following endogenous compounds were found not to interfere with test results when tested up to the concentrations identified in the table below.

<table><tr><td rowspan=1 colspan=1>Interfering Substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>2.5 μg/mL</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>2.5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Dextrose</td><td rowspan=1 colspan=1>20 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Gamma Globulin</td><td rowspan=1 colspan=1>5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1.2 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Human Serum Albumin</td><td rowspan=1 colspan=1>5 mg/mL</td></tr><tr><td rowspan=1 colspan=1>SodiumChloride</td><td rowspan=1 colspan=1>30 mg/mL</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>30 mg/mL</td></tr></table>

# Specific gravity and pH

The effect of specific gravity for each analyte was evaluated by testing positive and negative samples at specific gravities ranging from 1.003 to $1 . 0 3 0 \ : \mathrm { g / m L }$ . No interference was observed for all specific gravities tested.

The effect of $\mathsf { p H }$ for each analyte was evaluated by testing positive and negative samples over a range of $\mathsf { p H }$ levels of 4.0 to 9.0. Within the $\mathsf { p H }$ range of 4.0 to 9.0 acceptable results were observed with the samples tested. However, a low level of interference was noted with the TCA assay as the $\mathsf { p H }$ increased which could impact results which are above the threshold of $1 { , } 0 0 0 \mathrm { n g / m L }$ . Specimens tested outside of the validated pH range of 4.0 to 9.0 may yield inaccurate results.

The sponsor has included the following statement under ‘Warnings and Precautions’ section of the labeling:

“The Quidel Triage TOX Drug Screen, 94600 has been validated with specimens that have a pH range of $4 . 0 - 9 . 0$ acceptable results were observed with the samples tested. However, a low level of interference was noted with the TCA assay as the pH increased which could impact results which are above the threshold of $I , 0 0 0 n g / m L$ . Specimens tested outside of the validated pH range may yield inaccurate results.”

# Operating Temperature

The effect of operating temperature for each analyte was evaluated by testing positive and negative samples at temperatures ranging from $1 6 \mathrm { { } ^ { \circ } C }$ to $3 0 \mathrm { { } ^ { \circ } C }$ ( $6 1 ^ { \circ } \mathrm { F }$ to $8 6 ^ { \circ } \mathrm { F }$ ). Based on the study results, the Quidel Triage TOX Drug Screen, 94600 is validated for an operating temperature range from $1 8 ^ { \circ } \mathrm { C }$ to $2 8 ^ { \circ } \mathrm { C }$ ( $6 4 ^ { \circ } \mathrm { F }$ to $8 2 ^ { \circ } \mathrm { F }$ ).

# Operating Humidity

The effect of operating humidity for each analyte was evaluated by testing positive and negative samples at relative humidities (R.H.) ranging from $\leq 1 0 \ \% \mathrm { R . H }$ . to 85 $\% \mathrm { R H }$ . The Quidel Triage TOX Drug Screen, 94600 is validated for an operating relative humidity (R.H.) range from $1 0 \ \% \mathrm { R . H }$ . to $8 5 ~ \% \mathrm { R . H }$ . for all analyte assays.

The sponsor has included the following statement in the devicelabeling under the ‘Warnings and Precautions’ section:

“Optimal results will be achieved by performing testing at temperatures between $I \delta ^ { \circ } C$ to $2 8 \mathrm { { ^ \circ C } }$ $6 4 ^ { \circ } F$ to $8 2 ^ { \circ } F _ { \prime }$ ) and between a relative humidity (RH) range of $10 \% R H$ to $8 5 \ \% R H .$ Specimens tested outside of the validated temperature range may yield inaccurate results particularly for the cocaine, methamphetamines and opiates assays.”

# f. Assay cut-off:

Each analyte for the cutoff characterization study was tested at the following concentrations: 0, $2 5 \%$ , $50 \%$ , $7 5 \%$ , $100 \%$ , $+ 1 2 5 \%$ , $+ 1 5 0 \%$ , $+ 1 7 5 \%$ and $+ 2 0 0 \%$ of the specific cutoff for each drug assay. Testing was performed using 3 lots of Quidel Triage TOX Drug Screen, 94600 Test Devices and was performed by 3 operators

over four days. Each test sample was run on 105 test devices per device lot for a total of 315 results per sample. For each test device lot, 40 unique meters were used to complete all test measurements. Combined results from three test device lots for each drug test is summarized below.

<table><tr><td rowspan=1 colspan=3>Amphetamine (AMP) 500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1>Results#Neg/#Pos</td></tr><tr><td rowspan=1 colspan=1>NegativeControl</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>281</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>395</td><td rowspan=1 colspan=1>75%</td><td rowspan=1 colspan=1>313/2</td></tr><tr><td rowspan=1 colspan=1>522</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>49/266</td></tr><tr><td rowspan=1 colspan=1>650</td><td rowspan=1 colspan=1>125%</td><td rowspan=1 colspan=1>1/314</td></tr><tr><td rowspan=1 colspan=1>760</td><td rowspan=1 colspan=1>150%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>884</td><td rowspan=1 colspan=1>175%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>991</td><td rowspan=1 colspan=1>200%</td><td rowspan=1 colspan=1>0/315</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Methamphetamine (mAMP) 500 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1">Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">130</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">50%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">366</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1">312/3</td></tr><tr><td colspan="1" rowspan="1">529</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">127/188</td></tr><tr><td colspan="1" rowspan="1">652</td><td colspan="1" rowspan="1">125%</td><td colspan="1" rowspan="1">11/304</td></tr><tr><td colspan="1" rowspan="1">742</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1">2/313</td></tr><tr><td colspan="1" rowspan="1">872</td><td colspan="1" rowspan="1">175%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">961</td><td colspan="1" rowspan="1">200%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="3" rowspan="1">Barbiturates (BAR) 200 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1">Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">53</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">108</td><td colspan="1" rowspan="1">50%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">156</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1">309/6</td></tr><tr><td colspan="1" rowspan="1">192</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">78/237</td></tr><tr><td colspan="1" rowspan="1">233</td><td colspan="1" rowspan="1">125%</td><td colspan="1" rowspan="1">1/314</td></tr><tr><td colspan="1" rowspan="1">306</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1">1/314</td></tr><tr><td colspan="1" rowspan="1">355</td><td colspan="1" rowspan="1">175%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">406</td><td colspan="1" rowspan="1">200%</td><td colspan="1" rowspan="1">0/315</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Benzodiazepines (BZO) 200 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1>Results#Neg/#Pos</td></tr><tr><td rowspan=1 colspan=1>NegativeControl</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>166</td><td rowspan=1 colspan=1>75%</td><td rowspan=1 colspan=1>296/19</td></tr><tr><td rowspan=1 colspan=1>219</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>242/73</td></tr><tr><td rowspan=1 colspan=1>259</td><td rowspan=1 colspan=1>125%</td><td rowspan=1 colspan=1>3/312</td></tr><tr><td rowspan=1 colspan=1>306</td><td rowspan=1 colspan=1>150%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>378</td><td rowspan=1 colspan=1>175%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>399</td><td rowspan=1 colspan=1>200%</td><td rowspan=1 colspan=1>0/315</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Cocaine (COC) 150 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1">Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">76</td><td colspan="1" rowspan="1">50%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">119</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1">279/36</td></tr><tr><td colspan="1" rowspan="1">157</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">10/305</td></tr><tr><td colspan="1" rowspan="1">185</td><td colspan="1" rowspan="1">125%</td><td colspan="1" rowspan="1">1/314</td></tr><tr><td colspan="1" rowspan="1">218</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">267</td><td colspan="1" rowspan="1">175%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">200%</td><td colspan="1" rowspan="1">0/315</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Methadone Metabolite (EDDP) 100 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1>Results#Neg/#Pos</td></tr><tr><td rowspan=1 colspan=1>NegativeControl</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>85</td><td rowspan=1 colspan=1>75%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>115/200</td></tr><tr><td rowspan=1 colspan=1>136</td><td rowspan=1 colspan=1>125%</td><td rowspan=1 colspan=1>11/304</td></tr><tr><td rowspan=1 colspan=1>143</td><td rowspan=1 colspan=1>150%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>174</td><td rowspan=1 colspan=1>175%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>204</td><td rowspan=1 colspan=1>200%</td><td rowspan=1 colspan=1>0/315</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Opiates (OPI) 300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1">Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">165</td><td colspan="1" rowspan="1">50%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">231</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">344</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">132/183</td></tr><tr><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">125%</td><td colspan="1" rowspan="1">1/314</td></tr><tr><td colspan="1" rowspan="1">480</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">548</td><td colspan="1" rowspan="1">175%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">589</td><td colspan="1" rowspan="1">200%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="3" rowspan="1">Cannabinoids (THC) 50 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1">Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="1">NegativeControl</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">50%</td><td colspan="1" rowspan="1">315/0</td></tr><tr><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1">295/20</td></tr><tr><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">20/295</td></tr><tr><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">125%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">78</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">175%</td><td colspan="1" rowspan="1">0/315</td></tr><tr><td colspan="1" rowspan="1">103</td><td colspan="1" rowspan="1">200%</td><td colspan="1" rowspan="1">0/315</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Tricyclic Antidepressants (TCA) 1000 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1>Results#Neg/#Pos</td></tr><tr><td rowspan=1 colspan=1>NegativeControl</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>236</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>498</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>315/0</td></tr><tr><td rowspan=1 colspan=1>741</td><td rowspan=1 colspan=1>75%</td><td rowspan=1 colspan=1>300/15</td></tr><tr><td rowspan=1 colspan=1>996</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>161/154</td></tr><tr><td rowspan=1 colspan=1>1,395</td><td rowspan=1 colspan=1>125%</td><td rowspan=1 colspan=1>5/310</td></tr><tr><td rowspan=1 colspan=1>1,577</td><td rowspan=1 colspan=1>150%</td><td rowspan=1 colspan=1>1/314</td></tr><tr><td rowspan=1 colspan=1>1,716</td><td rowspan=1 colspan=1>175%</td><td rowspan=1 colspan=1>0/315</td></tr><tr><td rowspan=1 colspan=1>2,195</td><td rowspan=1 colspan=1>200%</td><td rowspan=1 colspan=1>0/315</td></tr></table>

2. Comparison studies:

# a. Method comparison with predicate device:

A method comparison study was conducted using unaltered urine specimens tested on the Quidel Triage TOX Drug Screen, 94600 and compared to results from a chemically-specific quantitative comparator method. Results are summarized below.

Quidel Triage TOX Drug Screen, 94600 Test Results vs GC/MS or LC-MS/MS

Values

Discordant Results - Resolution   

<table><tr><td rowspan=1 colspan=2></td><td rowspan=1 colspan=4>Reference Method Result by GC/MS or LC-MS/MS Value</td></tr><tr><td rowspan=1 colspan=1>DRUG</td><td rowspan=1 colspan=1>QuidelTriageTOX DrugScreen,94600</td><td rowspan=1 colspan=1>Negative(&lt;50%ofthreshold)</td><td rowspan=1 colspan=1>NearThresholdNegative(within50% belowthreshold)</td><td rowspan=1 colspan=1>NearThresholdPositive(within50% abovethreshold)</td><td rowspan=1 colspan=1>Positive(&gt;150%ofthreshold)</td></tr><tr><td rowspan=2 colspan=1>AMP(500)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>2a</td><td rowspan=1 colspan=1>2b</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=2 colspan=1>mAMP(500)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5d</td><td rowspan=1 colspan=1>7e</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5c</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>91</td></tr><tr><td rowspan=2 colspan=1>BAR (200)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>8f</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=2 colspan=1>BZO (200)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1h</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10g</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>99</td></tr><tr><td rowspan=2 colspan=1>COC (150)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>6i</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>99</td></tr><tr><td rowspan=2 colspan=1>EDDP(100)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>2j</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1k</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=2 colspan=1>OPI (300)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1m</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=2 colspan=1>THC (50)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1n</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>99</td></tr><tr><td rowspan=2 colspan=1>TCA(1,000)</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1P</td><td rowspan=1 colspan=1>109</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>95</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MSvalue (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>569740a</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>697</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>575202</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>745</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>570964b</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>1003</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>572667b</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>1359</td></tr></table>

a These two patient specimens were read negative despite a near threshold positive results by the reference method.

These two patient specimens were read negative despite a high positive result. The Quidel Triage TOX Drug Screen, 94600 has $1 0 0 . 0 \%$ cross reactivity to the d‐ amphetamine isomer and $1 6 . 7 \%$ cross‐reactivity to the l‐amphetamine isomer, resulting in negative screening results even with amphetamine levels above the cutoff concentration of $5 0 0 ~ \mathrm { { n g / m L } }$ by the reference method. A specimen with high levels of the l‐ amphetamine isomer may be associated with prescription use of medications containing amphetamines or compounds that metabolize to amphetamines. A summary of the results for the patient specimens containing both isomers is presented in the table below. After adjudication, Specimen ID 570964 would be classified as “near threshold” negative and would not be classified as a discordant result. Specimen ID 572667 would be classified as a “near threshold” positive patient specimen (within $1 0 . 8 \%$ of the assay threshold).

<table><tr><td rowspan=2 colspan=1>Specimen ID</td><td rowspan=2 colspan=1>QuidelTriageTOXDrugScreen,94600AMPAssayCutoff(ng/mL)</td><td rowspan=2 colspan=1>InitialValuedeter-minedbyLC-MS/MS(ng/mL)</td><td rowspan=2 colspan=1>InitialQuidelTriageTOXDrugScreen,94600AMPAssayResult</td><td rowspan=1 colspan=2>IsomericComposition(%)</td><td rowspan=1 colspan=2>IsomericAbundance(ng/mL)</td><td rowspan=2 colspan=1>EffectiveAmphetamine(ng/mL)*</td><td rowspan=2 colspan=1>AdjudicatedQuidelTriage TOXDrugScreen,94600 AMPAssayResult</td></tr><tr><td rowspan=1 colspan=1>% d-Amphetamine</td><td rowspan=1 colspan=1>% l-Amphetamine</td><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>l-Amphetamine</td></tr><tr><td rowspan=1 colspan=1>570964b</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>1003</td><td rowspan=1 colspan=1>FalseNegative</td><td rowspan=1 colspan=1>35.3</td><td rowspan=1 colspan=1>64.7</td><td rowspan=1 colspan=1>354</td><td rowspan=1 colspan=1>649</td><td rowspan=1 colspan=1>463</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>572667b</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>1359</td><td rowspan=1 colspan=1>False egative</td><td rowspan=1 colspan=1>28.9</td><td rowspan=1 colspan=1>71.1</td><td rowspan=1 colspan=1>393</td><td rowspan=1 colspan=1>966</td><td rowspan=1 colspan=1>554</td><td rowspan=1 colspan=1>FalseNegative</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Assay</td><td colspan="1" rowspan="1">CutoffValue(ng/mL)</td><td colspan="1" rowspan="1">SpecimenID</td><td colspan="1" rowspan="1">Quidel TriageTOX DS 94600Result(POS/NEG)</td><td colspan="1" rowspan="1">Drug/MetaboliteDetected</td><td colspan="1" rowspan="1">GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">578510c</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">325</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579777c</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">402</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579705c</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">445</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579727c</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">490</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579806c</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">495</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586313d</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">535</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586273d</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">555</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579791d</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">588</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586280d</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">633</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586293d</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">673</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586276</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">831</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586269e</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">937</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586264</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">940</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586282</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">984</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586275</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">990</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">586300</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">1028</td></tr><tr><td colspan="1" rowspan="1">mAMP</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">579757e</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">1568</td></tr></table>

c Patient specimens with Specimen IDs 578510, 579777, 579705, 579727, and 579806 were found to be positive despite a near threshold negative result. d Patient specimens with Specimen IDs 586313, 586723, 579791, 586280 and 586293 were found to be negative despite a near threshold positive result. e Patient specimens with Specimen IDs 586276, 586269, 586264, 586282, 586275, 586300, and 579757 were found to be negative despite a high positive result. The specimens contained both the d-methamphetamine and l-methamphetamine isomers. The initial LC-MS/MS reference method was unable to distinguish between the two enantiomeric forms. The Quidel Triage TOX Drug Screen, 94600 has $1 0 0 . 0 \%$ crossreactivity to the d-methamphetamine isomer and $0 . 0 \%$ cross-reactivity to the lmethamphetamine isomer, resulting in negative screening results even with methamphetamine levels above the cutoff concentration of $5 0 0 ~ \mathrm { { n g / m L } }$ . A specimen with high levels of the l-methamphetamine isomer may be associated with prescription use of medications that contain methamphetamine or compounds that metabolize into methamphetamines. A summary of the results for the patient specimens containing both isomers is presented in the table below. After adjudication, Specimen IDs 586282, 586275 and 586300 were found to be negative despite a near threshold positive result (all within $8 . 6 \%$ of the assay threshold).

<table><tr><td colspan="1" rowspan="2">mAMPSpecimen ID</td><td colspan="1" rowspan="2">ReferenceLaboratory l LC-MS/MSConfirmatory Value(ng/mL)</td><td colspan="1" rowspan="2">QuidelTriage TOXDrugScreen,94600ThresholdConcentration (ng/mL)</td><td colspan="1" rowspan="2">QuidelTriage TOXDrugScreen,94600Result</td><td colspan="2" rowspan="1">ReferenceLaboratory 2Results</td><td colspan="1" rowspan="2">AdjudicatedQuidel TriageTOX DrugScreen, 94600Result</td></tr><tr><td colspan="1" rowspan="1">% d-Isomer</td><td colspan="1" rowspan="1">Concentration d-Isomer(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">586276e</td><td colspan="1" rowspan="1">831</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.3</td><td colspan="1" rowspan="1">434.6</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">586269e</td><td colspan="1" rowspan="1">937</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.8</td><td colspan="1" rowspan="1">494.7</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">586264e</td><td colspan="1" rowspan="1">940</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.9</td><td colspan="1" rowspan="1">497.3</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">586282</td><td colspan="1" rowspan="1">984</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.2</td><td colspan="1" rowspan="1">513.6</td><td colspan="1" rowspan="1">False Negative</td></tr><tr><td colspan="1" rowspan="1">586275e</td><td colspan="1" rowspan="1">990</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.3</td><td colspan="1" rowspan="1">517.8</td><td colspan="1" rowspan="1">False Negative</td></tr><tr><td colspan="1" rowspan="1">586300e</td><td colspan="1" rowspan="1">1028</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">52.8</td><td colspan="1" rowspan="1">542.8</td><td colspan="1" rowspan="1">False Negative</td></tr><tr><td colspan="1" rowspan="1">579757e</td><td colspan="1" rowspan="1">1568</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">FalseNegative</td><td colspan="1" rowspan="1">19.9</td><td colspan="1" rowspan="1">312.0</td><td colspan="1" rowspan="1">Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>582858f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>120</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575082f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>172</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575081f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575079f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>151</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>586932f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>164</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575085f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575084f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>210</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>575095f</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>197</td></tr></table>

f Patient specimens with Specimen IDs 582858, 575082, 575081, 575079, 586932, 575085, 575084, and 575095 were found to be positive despite a near threshold negative result.

<table><tr><td colspan="1" rowspan="1">Assay</td><td colspan="1" rowspan="1">CutoffValue(ng/mL)</td><td colspan="1" rowspan="1">SpecimenID</td><td colspan="1" rowspan="1">Quidel TriageTOX DS 94600Result (POS/NEG)</td><td colspan="1" rowspan="1">Drug/MetaboliteDetected</td><td colspan="1" rowspan="1">GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">586239g</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">79</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">586234g</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">80</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">586235g</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">86</td></tr><tr><td colspan="1" rowspan="3">BZO</td><td colspan="1" rowspan="3">200</td><td colspan="1" rowspan="3">582865g</td><td colspan="1" rowspan="3">False Positive</td><td colspan="1" rowspan="1">7-aminoclonazepam</td><td colspan="1" rowspan="1">293</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">53</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">379</td></tr><tr><td colspan="1" rowspan="4">BZO</td><td colspan="1" rowspan="4">200</td><td colspan="1" rowspan="4">570784g</td><td colspan="1" rowspan="4">False Positive</td><td colspan="1" rowspan="1">7-aminoclonazepam</td><td colspan="1" rowspan="1">1134</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">63</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">124</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">90</td></tr><tr><td colspan="1" rowspan="2">BZO</td><td colspan="1" rowspan="2">200</td><td colspan="1" rowspan="2">569935g</td><td colspan="1" rowspan="2">False Positive</td><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">68</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">244</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">93</td></tr><tr><td colspan="1" rowspan="2">BZO</td><td colspan="1" rowspan="2">200</td><td colspan="1" rowspan="2">585873g</td><td colspan="1" rowspan="2">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">105</td></tr><tr><td colspan="1" rowspan="1">7-aminoclonazepam</td><td colspan="1" rowspan="1">2500</td></tr><tr><td colspan="1" rowspan="3">BZO</td><td colspan="1" rowspan="3">200</td><td colspan="1" rowspan="3">570860g</td><td colspan="1" rowspan="3">False Positive</td><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">83</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">218</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">126</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">570941g</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">126</td></tr><tr><td colspan="1" rowspan="2">BZO</td><td colspan="1" rowspan="2">200</td><td colspan="1" rowspan="2">578527g</td><td colspan="1" rowspan="2">False Positive</td><td colspan="1" rowspan="1">Alprazolam-OH</td><td colspan="1" rowspan="1">129</td></tr><tr><td colspan="1" rowspan="1">7-aminoclonazepam</td><td colspan="1" rowspan="1">146</td></tr><tr><td colspan="1" rowspan="1">BZO</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">578563h</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">214</td></tr></table>

g Patient specimens with Specimen IDs 586239, 586234, 586235, 582865, 570784, 569935, 585873, 570860, 570941, and 578527 were found to be positive despite a near threshold negative result. h Patient specimen with Specimen ID 578563 was found to be negative despite a near threshold positive result.

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>569915i</td><td rowspan=1 colspan=1>COC False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>113</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>579796i</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>579821</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>128</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>569790i</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>129</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>570955i</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>144</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>577368i</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>144</td></tr></table>

i Patient specimens with Specimen IDs 569915, 579796, 579821, 569790, 570955 and 577368 were found to be positive despite a near threshold negative result.

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>572444i</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>76</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>572432k</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>572426k</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>110</td></tr></table>

j Patient specimen with Specimen ID 572444 was found to be positive despite a near threshold negative result.

k Patient specimens with Specimen IDs 572432 and 572426 were found to be negative despite a near threshold positive result.

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5725081</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>353</td></tr><tr><td rowspan=2 colspan=1>OPI</td><td rowspan=2 colspan=1>300</td><td rowspan=2 colspan=1>5704151</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>24859</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>217</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5863271</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>228</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5828601</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>469</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5724881</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>239</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5863301</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>260</td></tr><tr><td rowspan=2 colspan=1>OPI</td><td rowspan=2 colspan=1>300</td><td rowspan=2 colspan=1>5829321</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>488</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>67</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>5863291</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>285</td></tr><tr><td rowspan=3 colspan=1>OPI</td><td rowspan=3 colspan=1>300</td><td rowspan=3 colspan=1>572644m</td><td rowspan=3 colspan=1>False Negative</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2097</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>2674</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>137</td></tr></table>

l Patient specimens with Specimen IDs 572508, 570415, 586327, 582860, 572488, 586330, 582932 and 586359 were found to be positive despite a near threshold negative result.

m Patient specimen with Specimen ID 572644 was found to be negative despite a high positive result. The initial reference testing laboratory result for Specimen ID 572644 was positive for opiates while the Quidel Triage TOX Drug Screen, 94600 OPI assay result was negative. Specimen ID 572644 was sent to a second reference testing laboratory and was confirmed to be negative for opiates. The second result is concordant with the Quidel Triage TOX Drug Screen, 94600 OPI assay result.

<table><tr><td colspan="1" rowspan="1">Assay</td><td colspan="1" rowspan="1">CutoffValue(ng/mL)</td><td colspan="1" rowspan="1">SpecimenID</td><td colspan="1" rowspan="1">Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td colspan="1" rowspan="1">Drug/MetaboliteDetected</td><td colspan="1" rowspan="1">GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">570021n</td><td colspan="1" rowspan="1">False Positive</td><td colspan="1" rowspan="1">11-nor-9-Carboxy-delta 9-THC</td><td colspan="1" rowspan="1">31</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">570366°</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">11-nor-9-Carboxy-delta 9-THC</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">575089°</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">11-nor-9-Carboxy-delta 9-THC</td><td colspan="1" rowspan="1">56</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">569400°</td><td colspan="1" rowspan="1">False Negative</td><td colspan="1" rowspan="1">11-nor-9-</td><td colspan="1" rowspan="1">63</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Carboxy-delta 9-THC</td><td colspan="1" rowspan="1"></td></tr></table>

n Patient specimen with Specimen ID 570021 was found to be positive despite a near threshold negative result. o Patient specimens with Specimen IDs 570366, 575089, and 569400 were found to be negative despite a near threshold positive result.

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>SpecimenID</td><td rowspan=1 colspan=1>Quidel Triage TOXDS 94600 Result(POS/NEG)</td><td rowspan=1 colspan=1>Drug/MetaboliteDetected</td><td rowspan=1 colspan=1>GC/MS orLC/MS/MS value(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>586712P</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5863539</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>637</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5858789</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>639</td></tr><tr><td rowspan=2 colspan=1>TCA</td><td rowspan=2 colspan=1>1,000</td><td rowspan=2 colspan=1>5829369</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>385</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>160</td></tr><tr><td rowspan=2 colspan=1>TCA</td><td rowspan=2 colspan=1>1,000</td><td rowspan=2 colspan=1>5725819</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>149</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>512</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5858669</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>680</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5862329</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>727</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5858309</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>730</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>5858799</td><td rowspan=1 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>758</td></tr><tr><td rowspan=2 colspan=1>TCA</td><td rowspan=2 colspan=1>1,000</td><td rowspan=2 colspan=1>5829259</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>162</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>599</td></tr><tr><td rowspan=2 colspan=1>TCA</td><td rowspan=2 colspan=1>1,000</td><td rowspan=2 colspan=1>5858749</td><td rowspan=2 colspan=1>False Positive</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>608</td></tr><tr><td rowspan=1 colspan=1>Doxepin</td><td rowspan=1 colspan=1>238</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>586694r</td><td rowspan=1 colspan=1>False Negative</td><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>1646</td></tr></table>

p Patient specimen with Specimen ID 586712 was found to be positive despite a high negative result. A data entry error occurred with Specimen ID 586712. This patient specimen was positive for TCA when tested on the Quidel Triage TOX Drug Screen, 94600 and reconfirmed as a near cut-off negative at a secondary reference testing laboratory with value of $8 6 4 ~ \mathrm { { n g / m L } }$ desipramine (within $1 0 . 8 \%$ of the assay threshold).

q Patient specimens with Specimen IDs 586353, 585878, 582936, 572581, 585866, 586232, 585830, 585879, 582925, and 585874 were found to be positive despite a near threshold negative result.

r Patient specimen with Specimen ID 586694 was found to be negative despite a high positive result. Specimen ID 586694 was confirmed to have a $\mathsf { p H }$ value of 9.4. A pH value at this level is above the upper limit of the expected range for normal human urine 8 and above the upper limit evaluated for performance on the Quidel Triage TOX Drug Screen, 94600. The Quidel Triage TOX Drug Screen, 94600 has been

validated with specimens that have a $\mathsf { p H }$ range of 4.0 – 9.0 acceptable results were observed with the samples tested. However, a low level of interference was noted with the TCA assay as the $\mathsf { p H }$ increased which could impact results which are above the threshold of $1 { , } 0 0 0 \mathrm { n g / m L }$ . Specimens tested outside of the validated $\mathsf { p H }$ range may yield inaccurate results.

b. Matrix comparison: Not applicable. These devices are for use with human urine samples only.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

N. Instrument Name: Quidel Triage® MeterPro

# O. System Descriptions:

1. Modes of Operation:

Does the applicant’s device contain the ability to transmit data to a computer, webserver, or mobile device?

Yes ___ _X____ or No

Does the applicant’s device transmit data to a computer, webserver, or mobile device

using wireless transmission? Yes _ or No ___X_

2. Software:

FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:

Yes ___X_ __ or No

3. Specimen Identification:

There is no sample identification function with this device. Samples are applied directly to the test device.

4. Specimen Sampling and Handling:

This device is intended to be used with urine samples. The labeling provides instructions for storage of samples.

5. Calibration:

Lot Calibration of the meter is performed using Reagent CODE CHIP Module which is specific to each lot of the test device.

6. Quality Control:

For the meter quality control, the device operator installs the QC Device CODE CHIP Module in the meter. After installation, the operator runs the QC Device every day prior to running the external quality control samples and patient samples to assess the functioning of the meter lasers etc.

The QC Sample CODE CHIP module is lot specific. The operator installs the QC Sample CODE CHIP module in the meter prior to testing of the external QC samples (Control 1 and 2).

The sponsor specifies in the labeling the quality control products that must be used with the device systems.

P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above:

Not applicable.

# Q. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Parts 801 and 809, as applicable.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.